BetterScholar BetterScholar
13
Role
Title
Level Year L/R
🐜 The polycomb group protein EZH2 is involved in progression of prostate cancer
12 auth. S. Varambally, S. Dhanasekaran, Ming Zhou, T. Barrette, Chandan Kumar-Sinha, M. Sanda, ... D. Ghosh, K. Pienta, R. Sewalt, A. Otte, M. Rubin, A. Chinnaiyan
11 2002
11
🐜
🐢 Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
John T. Wei, R. Dunn, R. Dunn, M. Litwin, H. Sandler, M. Sanda
10 2000
10
🐢
🦁 Quality of life and satisfaction with outcome among prostate-cancer survivors.
20 auth. M. Sanda, R. Dunn, J. Michalski, H. Sandler, L. Northouse, L. Hembroff, Xihong Lin, T. Greenfield, M. Litwin, C. Saigal, ... A. Mahadevan, E. Klein, A. Kibel, L. Pisters, D. Kuban, I. Kaplan, D. Wood, J. Ciezki, N. Shah, John T. Wei
10 2008
10
🦁
🦁 Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
15 auth. M. Sanda, J. Cadeddu, Erin Kirkby, Ronald C. Chen, Tony Crispino, J. Fontanarosa, S. Freedland, Kirsten L. Greene, L. Klotz, D. Makarov, ... J. Nelson, G. Rodrigues, H. Sandler, M. Taplin, J. Treadwell
9 2017
9
🦁
🐜 Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group.
12 auth. M. Tuck, D. Chan, D. Chia, A. Godwin, W. Grizzle, K. Krueger, ... W. Rom, M. Sanda, L. Sorbara, S. Stass, Wendy Wang, D. Brenner
9 2009
9
🐜
🐜 Autoantibody signatures in prostate cancer.
15 auth. Xiaoju Wang, Jianjun Yu, A. Sreekumar, S. Varambally, R. Shen, D. Giacherio, R. Mehra, J. Montie, K. Pienta, M. Sanda, ... P. Kantoff, M. Rubin, John T. Wei, D. Ghosh, A. Chinnaiyan
9 2005
9
🐜
🐜 alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
9 auth. M. Rubin, Ming Zhou, S. Dhanasekaran, S. Varambally, T. Barrette, M. Sanda, ... K. Pienta, D. Ghosh, A. Chinnaiyan
9 2002
9
🐜
🐜 An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
29 auth. Caroline S. Jansen, Nataliya Prokhnevska, V. Master, M. Sanda, J. Carlisle, M. Bilen, M. Cardenas, S. Wilkinson, Ross Lake, A. Sowalsky, R. Valanparambil, W. Hudson, D. McGuire, K. Melnick, A. I. Khan, ... K. Kim, Y. Chang, Alice Kim, C. Filson, M. Alemozaffar, A. Osunkoya, Patrick Mullane, C. Ellis, Rama S. Akondy, S. Im, A. Kamphorst, A. Reyes, Yuan Liu, H. Kissick
9 2019
9
🐜
🐢 Contemporary diagnosis and management of renal angiomyolipoma.
C. Nelson, M. Sanda
8 2002
8
🐢
🐜 Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.
20 auth. J. Simons, B. Mikhak, Ju-Fay Chang, A. DeMarzo, M. Carducci, M. Lim, C. Weber, A. Baccala, M. Goemann, S. Clift, ... D. Ando, H. Levitsky, L. Cohen, M. Sanda, R. Mulligan, A. Partin, H. Carter, S. Piantadosi, F. Marshall, W. Nelson
8 1999
8
🐜
🐜 A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.
17 auth. W. Catalona, A. Partin, M. Sanda, John T. Wei, G. Klee, C. Bangma, K. Slawin, L. Marks, S. Loeb, D. L. Broyles, ... Sanghyuk S. Shin, Amabelle B. Cruz, D. Chan, L. Sokoll, W. Roberts, R. V. van Schaik, I. Mizrahi
8 2011
8
🐜
🐢 Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.
8 auth. John T. Wei, R. Dunn, H. Sandler, P. Mclaughlin, J. Montie, M. Litwin, ... L. Nyquist, M. Sanda
8 2002
8
🐢
🐢 Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.
K. Szymanski, John T. Wei, R. Dunn, M. Sanda
8 2010
8
🐢